Oral Challenge without Skin Testing Safely Excludes Clinically Significant Delayed-Onset Penicillin Hypersensitivity.

MLA

Confino-Cohen, Ronit, et al. “Oral Challenge without Skin Testing Safely Excludes Clinically Significant Delayed-Onset Penicillin Hypersensitivity.” The Journal of Allergy and Clinical Immunology. In Practice, vol. 5, no. 3, May 2017, pp. 669–75. EBSCOhost, https://doi.org/10.1016/j.jaip.2017.02.023.

APA

Confino-Cohen, R., Rosman, Y., Meir-Shafrir, K., Stauber, T., Lachover-Roth, I., Hershko, A., & Goldberg, A. (2017). Oral Challenge without Skin Testing Safely Excludes Clinically Significant Delayed-Onset Penicillin Hypersensitivity. The Journal of Allergy and Clinical Immunology. In Practice, 5(3), 669–675. https://doi.org/10.1016/j.jaip.2017.02.023

Chicago

Confino-Cohen, Ronit, Yossi Rosman, Keren Meir-Shafrir, Tali Stauber, Idit Lachover-Roth, Alon Hershko, and Arnon Goldberg. 2017. “Oral Challenge without Skin Testing Safely Excludes Clinically Significant Delayed-Onset Penicillin Hypersensitivity.” The Journal of Allergy and Clinical Immunology. In Practice 5 (3): 669–75. doi:10.1016/j.jaip.2017.02.023.